Clinical Trials Browser

Phase 2 × Terminated × dactolisib × Clear all

NCT01856101 2019-04-10

BEZ235

Phase 2 Terminated

Carcinoma, Transitional Cell

NCT01628913 2016-04-07

Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

Phase 2 Terminated

62 enrolled 7 charts

Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors